Abrams Bison Investments 13F, Q4 2023

Abrams Bison · quarter ending 31 December 2023 · filed 14 February 2024 · SEC CIK 1317588

$997.60M
Filed US book
11
Positions
24.3%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q4 2023

Weights are against the whole filed book. Changes are in shares held, against the Q3 2023 filing.

CompanyTickerValue% of bookvs Q3 2023
TD SYNNEX CORPORATIONSNX$241.91M24.3%unchanged
HCA HEALTHCARE INCHCA$148.87M14.9%+21% shares
APPLIED MATLS INCAMAT$147.48M14.8%unchanged
CREDIT ACCEP CORP MICHCACC$87.37M8.8%unchanged
CAPITAL ONE FINL CORPCOF$76.18M7.6%unchanged
INTERACTIVE BROKERS GROUP INIBKR$75.60M7.6%unchanged
JPMORGAN CHASE & COJPM$70.42M7.1%unchanged
PIONEER NAT RES CO$67.91M6.8%-6% shares
NEXSTAR MEDIA GROUP INCNXST$45.77M4.6%unchanged
STONECO LTD$25.24M2.5%-66% shares
SELECTQUOTE INCSLQT$10.84M1.1%unchanged

What changed since Q3 2023

Against the Q3 2023 filing, Abrams Bison Investments opened 0 new positions, added to 1, trimmed 2, left 8 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

No new positions this quarter.

Exited

Nothing from the previous filing was sold outright.

Added to

  • HCA+21%$148.87M

Trimmed

  • PIONEER NAT RES CO-6%$67.91M
  • STONECO LTD-66%$25.24M

Other quarters

Source: SEC Form 13F-HR, accession 0000919574-24-001487, filed by ABRAMS BISON INVESTMENTS, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.